Dasatinib-Induced Autophagy Is Enhanced in Combination With Temozolomide in Glioma

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-08-0669
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting Autophagy to Sensitive Glioma to Temozolomide Treatment

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2016English

Inhibition of Mitochondria- And Endoplasmic Reticulum Stress-Mediated Autophagy Augments Temozolomide-Induced Apoptosis in Glioma Cells

PLoS ONE
Multidisciplinary
2012English

Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities

Frontiers in Oncology
Cancer ResearchOncology
2019English

Dasatinib-Induced Pulmonary Arterial Hypertension Treated With Upfront Combination Therapy

Case Reports in Cardiology
Cardiovascular MedicineCardiology
2018English

Combination of 6-Thioguanine, Capecitabine, and Celecoxib With Temozolomide or Lomustine for Recurrent High-Grade Glioma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2010English

Combination of Paclitaxel Thermal Gel Depot With Temozolomide and Radiotherapy Significantly Prolongs Survival in an Experimental Rodent Glioma Model

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2012English

The Role of Autophagy Inhibition in the Enhanced Cytotoxicity of Temozolomide on Melanoma Cell Lines

Advances in molecular oncology
2017English

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma

World Journal of Oncology
Cancer ResearchOncology
2014English

Autophagy Inhibition Sensitizes LY3023414-induced Anti-Glioma Cell Activity in Vitro and in Vivo

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy